These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26996583)

  • 1. Simple Purification of Adeno-Associated Virus-DJ for Liver-Specific Gene Expression.
    Liu J; Moon YA
    Yonsei Med J; 2016 May; 57(3):790-4. PubMed ID: 26996583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single point mutation in adeno-associated viral vectors -DJ capsid leads to improvement for gene delivery in vivo.
    Mao Y; Wang X; Yan R; Hu W; Li A; Wang S; Li H
    BMC Biotechnol; 2016 Jan; 16():1. PubMed ID: 26729248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the relationship of AAV capsid domain swapping to liver transduction efficiency.
    Shen X; Storm T; Kay MA
    Mol Ther; 2007 Nov; 15(11):1955-62. PubMed ID: 17726459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein.
    Mori S; Wang L; Takeuchi T; Kanda T
    Virology; 2004 Dec; 330(2):375-83. PubMed ID: 15567432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bat adeno-associated viruses as gene therapy vectors with the potential to evade human neutralizing antibodies.
    Li Y; Li J; Liu Y; Shi Z; Liu H; Wei Y; Yang L
    Gene Ther; 2019 Jun; 26(6):264-276. PubMed ID: 31110296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses.
    Grimm D; Lee JS; Wang L; Desai T; Akache B; Storm TA; Kay MA
    J Virol; 2008 Jun; 82(12):5887-911. PubMed ID: 18400866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
    Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
    Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection.
    Yang L; Jiang J; Drouin LM; Agbandje-McKenna M; Chen C; Qiao C; Pu D; Hu X; Wang DZ; Li J; Xiao X
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3946-51. PubMed ID: 19234115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid.
    Vandenberghe LH; Wang L; Somanathan S; Zhi Y; Figueredo J; Calcedo R; Sanmiguel J; Desai RA; Chen CS; Johnston J; Grant RL; Gao G; Wilson JM
    Nat Med; 2006 Aug; 12(8):967-71. PubMed ID: 16845388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K137R mutation on adeno-associated viral capsids had minimal effect on enhancing gene delivery in vivo.
    Qiao C; Li C; Zhao C; Li J; Bian T; Grieger J; Li J; Samulski RJ; Xiao X
    Hum Gene Ther Methods; 2014 Feb; 25(1):33-9. PubMed ID: 24116972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivo.
    Li C; Hirsch M; Asokan A; Zeithaml B; Ma H; Kafri T; Samulski RJ
    J Virol; 2007 Jul; 81(14):7540-7. PubMed ID: 17475652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient production of recombinant adeno-associated viral vector, serotype DJ/8, carrying the GFP gene.
    Hashimoto H; Mizushima T; Chijiwa T; Nakamura M; Suemizu H
    Virus Res; 2017 Jun; 238():63-68. PubMed ID: 28571759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient AAV1-AAV2 hybrid vector for gene therapy of hemophilia.
    Hauck B; Xu RR; Xie J; Wu W; Ding Q; Sipler M; Wang H; Chen L; Wright JF; Xiao W
    Hum Gene Ther; 2006 Jan; 17(1):46-54. PubMed ID: 16409124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directed evolution of adeno-associated virus (AAV) as vector for muscle gene therapy.
    Yang L; Li J; Xiao X
    Methods Mol Biol; 2011; 709():127-39. PubMed ID: 21194025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes.
    Li H; Murphy SL; Giles-Davis W; Edmonson S; Xiang Z; Li Y; Lasaro MO; High KA; Ertl HC
    Mol Ther; 2007 Apr; 15(4):792-800. PubMed ID: 17245353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric AAV Cap sequences alter gene transduction.
    Ward P; Walsh CE
    Virology; 2009 Apr; 386(2):237-48. PubMed ID: 19232422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of gene transfer to the murine liver following intraperitoneal and intraportal delivery of hepatotropic AAV pseudo-serotypes.
    Dane AP; Wowro SJ; Cunningham SC; Alexander IE
    Gene Ther; 2013 Apr; 20(4):460-4. PubMed ID: 22895507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transduction with recombinant adeno-associated virus is primarily restricted by capsid serotype not vector genotype.
    Grimm D; Pandey K; Nakai H; Storm TA; Kay MA
    J Virol; 2006 Jan; 80(1):426-39. PubMed ID: 16352567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAV-mediated liver-directed gene therapy.
    Sands MS
    Methods Mol Biol; 2011; 807():141-57. PubMed ID: 22034029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.